David Setas-Guerrero
Pamplona, NC 31008, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Insights into ctDNA assessment to detect minimal residual disease (MRD) in localized colorectal cancer.
Journal: Scientific reports
Published: March 23, 2026
Primary Cutaneous Acral CD8-Positive Lymphoproliferative Disorder: A Case Report With Nonacral Presentation.
Journal: International journal of surgical pathology
Published: May 01, 2024
Biphasic papillary (biphasic squamoid alveolar) renal cell carcinoma: a clinicopathologic and molecular study of 17 renal cell carcinomas including 10 papillary adenomas.
Journal: Virchows Archiv : an international journal of pathology
Published: December 03, 2023
ZEB1 hypermethylation is associated with better prognosis in patients with colon cancer.
Journal: Clinical epigenetics
Published: September 09, 2023
A Novel Prognostic Biomarker Panel for Early-Stage Colon Carcinoma.
Journal: Cancers
Published: September 28, 2021
A DNA Methylation-Based Gene Signature Can Predict Triple-Negative Breast Cancer Diagnosis.
Journal: Biomedicines
Published: July 19, 2021
Understanding the Molecular Mechanism of miR-877-3p Could Provide Potential Biomarkers and Therapeutic Targets in Squamous Cell Carcinoma of the Cervix.
Journal: Cancers
Published: March 09, 2021
Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix.
Journal: International journal of molecular sciences
Published: February 07, 2020
ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer.
Journal: International journal of molecular sciences
Published: January 14, 2020
Last Updated: 09/26/2026